UP
Upstream Bio, Inc. (UPB)
NASDAQ·Healthcare·Biotechnology
$9.33
+0.43%
Mkt Cap $506.11M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$49.00
Range $47.00 – $51.00
Implied Upside
+425.2%
Consensus $49.00 vs current $9.33
NASDAQ·Healthcare·Biotechnology
$9.33
+0.43%
Mkt Cap $506.11M
No recent rating data.
Price Target (3 analysts)
$49.00
Range $47.00 – $51.00
+425.2%
Consensus $49.00 vs current $9.33